azacitidine has been researched along with Cytomegalovirus in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, EJ; Eun, K; Hong, N; Hwang, SU; Hwang, WS; Hyun, SH; Jeong, YIK; Jeong, YW; Kim, H; Olsson, PO; Park, MG | 1 |
| Abdullah, S; Al Abbar, A; Alhaji, SY; Mei, L; Ngai, SC; Nordin, N | 1 |
| Bartek, J; Beltoft Brøchner, C; Broholm, H; Davoudi, B; Ekström, TJ; Estekizadeh, A; Karimi, M; Landázur, N; Rahbar, A | 1 |
| Davoudi, B; Ekström, TJ; Estekizadeh, A; Hu, LF; Landázuri, N; Nawaz, I; Pantalone, MR; Rahbar, A; Stragliotto, G | 1 |
| Akkamsetty, Y; Callen, DF; Ho, K; Kumar, R; Lim, SP; Neilsen, PM; Prestidge, C; Suetani, RJ; Walther, DJ; Wang, W | 1 |
| Cang, M; Gao, XY; He, N; Liang, H; Liu, DJ; Nuo, MT; Yang, WL; Yuan, JL | 1 |
| Adams, PD; Einarson, MB; Katz, RA; Poleshko, A; Shalginskikh, N; Skalka, AM; Zhang, R | 1 |
| Cemazar, M; Kamensek, U; Kranjc, S; Sersa, G; Tevz, G; Vidic, S | 1 |
| Chusainow, J; Yang, Y; Yap, MG | 1 |
| Kong, Q; Li, L; Liu, X; Liu, Z; Mu, Y; Wang, Z; Wu, M; Zhang, X | 1 |
| Hu, K; Kong, QR; Liu, ZH; Mu, YS; Wu, ML; Yin, Z; Zhao, ZP | 1 |
| D'Ambrosio, E; Di Nardo, P; Grassi, G; Grassi, M; Kaiser, H; Kandolf, R; Kuhn, A; Küpper, JH; Maccaroni, P; Meyer, R; Pascale, E | 1 |
| El-Osta, A; Escher, G; Georges, S; Hoang, A; Krozowski, Z; Sviridov, D; Tchoua, U | 1 |
| Basma, H; Cheng, PW; Choi, KH; Singh, J | 1 |
| Basma, H; Cheng, PW; Christman, J; Klinkebiel, D; Radhakrishnan, P | 1 |
| Bailey, EC; Chen, WY; Dong, JY; McCune, SL; Townes, TM | 1 |
| Baskin, CR; Bunnell, BA; Case, SS; Kohn, DB; Lee, CI; Li, J; Newbound, GC; O'Rourke, JP; Tarantal, AF | 1 |
| Gentilomi, G; Gibellini, D; La Placa, M; Musiani, M; Zerbini, M | 1 |
18 other study(ies) available for azacitidine and Cytomegalovirus
| Article | Year |
|---|---|
Transcriptional activities of human elongation factor-1α and cytomegalovirus promoter in transgenic dogs generated by somatic cell nuclear transfer.
Topics: Animals; Animals, Genetically Modified; Azacitidine; Cells, Cultured; Cloning, Organism; Cytomegalovirus; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dogs; Embryo Transfer; Female; Fibroblasts; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Nuclear Transfer Techniques; Peptide Elongation Factor 1; Pregnancy; Promoter Regions, Genetic; Transcriptional Activation; Transfection; Transgenes | 2020 |
Lack of methylation on transgene leads to high level and persistent transgene expression in induced pluripotent stem cells.
Topics: Animals; Azacitidine; Cell Line; Cytomegalovirus; DNA Methylation; Embryonic Stem Cells; Eukaryotic Initiation Factor-1; Gene Expression Regulation; Green Fluorescent Proteins; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Promoter Regions, Genetic; Transduction, Genetic | 2020 |
Increased cytomegalovirus replication by 5-Azacytidine and viral-induced cytoplasmic expression of DNMT‑1 in medulloblastoma and endothelial cells.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cerebellar Neoplasms; Cytomegalovirus; Cytomegalovirus Infections; Cytoplasm; DNA (Cytosine-5-)-Methyltransferase 1; Human Umbilical Vein Endothelial Cells; Humans; Medulloblastoma; Viral Proteins; Virus Activation; Virus Replication | 2018 |
5‑Azacytidine treatment results in nuclear exclusion of DNA methyltransferase‑1, as well as reduced proliferation and invasion in human cytomegalovirus‑infected glioblastoma cells.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cytomegalovirus; Cytoplasm; Disease Progression; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Female; Glioblastoma; Humans; Male; Middle Aged; Treatment Outcome; Viral Envelope Proteins; Virus Replication | 2019 |
Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabine.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Breast; Carrier Proteins; Cells, Cultured; Cytomegalovirus; Decitabine; DNA Methylation; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Gene Expression Regulation; Genes, Reporter; Genetic Vectors; Humans; Hydroxamic Acids; Luminescent Proteins; Nitroreductases; Plasmids; Promoter Regions, Genetic; Red Fluorescent Protein; Repressor Proteins; RNA, Messenger; Unilamellar Liposomes; Vorinostat | 2013 |
Promoter methylation and histone modifications affect the expression of the exogenous DsRed gene in transgenic goats.
Topics: Animals; Animals, Genetically Modified; Azacitidine; Cytomegalovirus; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Dosage; Gene Expression; Gene Silencing; Goats; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Luminescent Proteins; Male; Promoter Regions, Genetic; Transgenes | 2016 |
Identification of a functional network of human epigenetic silencing factors.
Topics: Azacitidine; Cell Separation; Chromatin Assembly Factor-1; Clone Cells; Cytomegalovirus; DNA Methyltransferase 3A; Gene Knockdown Techniques; Gene Silencing; Genes, Reporter; Green Fluorescent Proteins; HeLa Cells; High-Throughput Screening Assays; Histones; Humans; Models, Genetic; Nuclear Proteins; Promoter Regions, Genetic; Protein Processing, Post-Translational; Repressor Proteins; Reproducibility of Results; RNA, Small Interfering; S Phase; Transcription Factors | 2010 |
Irradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: implementation of non-invasive fluorescence imaging.
Topics: Animals; Azacitidine; Cell Line, Tumor; Cisplatin; Cytomegalovirus; DNA Methylation; Female; Genes, Immediate-Early; Genes, Reporter; Infrared Rays; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microscopy, Fluorescence; Muscles; Promoter Regions, Genetic; Up-Regulation | 2011 |
DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines.
Topics: Animals; Antibodies, Monoclonal; Azacitidine; CHO Cells; Cricetinae; Cricetulus; Cytomegalovirus; DNA Methylation; Genes, Immediate-Early; Genetic Vectors; Humans; Interferon-gamma; Promoter Regions, Genetic; Trans-Activators; Transcription, Genetic | 2010 |
Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells.
Topics: Acetylation; Animals; Animals, Genetically Modified; Azacitidine; Cell Shape; Cell Survival; Cells, Cultured; Cytomegalovirus; Decitabine; DNA Methylation; Epigenesis, Genetic; Fibroblasts; Gene Expression Regulation; Green Fluorescent Proteins; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Methyltransferases; Promoter Regions, Genetic; Swine; Transgenes | 2011 |
Position effect variegation and epigenetic modification of a transgene in a pig model.
Topics: Animals; Animals, Genetically Modified; Azacitidine; Cell Line; Chromatin Assembly and Disassembly; Chromosomal Position Effects; Cytomegalovirus; Decitabine; DNA Methylation; Enzyme Inhibitors; Genetic Variation; Green Fluorescent Proteins; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Promoter Regions, Genetic; Swine; Transgenes | 2012 |
Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87.
Topics: Animals; Azacitidine; Cytomegalovirus; DNA Methylation; DNA Replication; Flow Cytometry; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioblastoma; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Models, Theoretical; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Synthesis Inhibitors; Time Factors; Transfection; Tumor Cells, Cultured | 2003 |
Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages.
Topics: Adenoviridae; Animals; Azacitidine; Cell Line; Cholestanetriol 26-Monooxygenase; Cholesterol; Cytomegalovirus; DEAE-Dextran; DNA; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, Reporter; Green Fluorescent Proteins; Humans; Lipids; Macrophages; Methylation; Mice; Microscopy, Confocal; Plasmids; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Steroid Hydroxylases; Transfection | 2005 |
Activation of CMV promoter-controlled glycosyltransferase and beta -galactosidase glycogenes by butyrate, tricostatin A, and 5-aza-2'-deoxycytidine.
Topics: Animals; Azacitidine; beta-Galactosidase; Butyrates; Cell Line, Tumor; Cricetinae; Cricetulus; Cytomegalovirus; Decitabine; DNA Modification Methylases; Drug Synergism; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Silencing; Glycosyltransferases; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Promoter Regions, Genetic; RNA, Messenger | 2005 |
Cell type-specific activation of the cytomegalovirus promoter by dimethylsulfoxide and 5-aza-2'-deoxycytidine.
Topics: Acetylation; Animals; Azacitidine; beta-Galactosidase; Cattle; Cell Line; Coumarins; Cricetinae; Cytomegalovirus; Decitabine; Dimethyl Sulfoxide; DNA Methylation; Dose-Response Relationship, Drug; Gene Expression Regulation, Viral; Histones; I-kappa B Kinase; Imidazoles; N-Acetylglucosaminyltransferases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Protein Biosynthesis; Pyridines; Time Factors; Transcription, Genetic; Up-Regulation | 2008 |
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.
Topics: Animals; Azacitidine; beta-Galactosidase; Butyrates; Butyric Acid; Cloning, Molecular; Cytomegalovirus; Dependovirus; Enzyme Inhibitors; Gene Expression; Genes, Reporter; Genetic Therapy; Genetic Vectors; Globins; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Polymerase Chain Reaction; Recombinant Proteins; Retroviridae; Transfection; Tumor Cells, Cultured | 1997 |
Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Topics: Animals; Azacitidine; Cytomegalovirus; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; HIV-1; Humans; Lentivirus; Leukocytes, Mononuclear; Luminescent Proteins; Macaca mulatta; Male; Membrane Glycoproteins; Models, Genetic; Moloney murine leukemia virus; Polymerase Chain Reaction; Promoter Regions, Genetic; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tissue Distribution; Viral Envelope Proteins | 2001 |
5-Azacytidine induction of a cellular heat shock protein and expression of the major immediate early protein of human cytomegalovirus in Vero cells.
Topics: Animals; Antigens, Viral; Azacitidine; Cytomegalovirus; Fluorescent Antibody Technique; Gene Expression Regulation, Viral; Heat-Shock Proteins; Humans; Immediate-Early Proteins; Immunoblotting; Vero Cells | 1991 |